Post-Acute Sequelae of COVID-19 (PASC) in Hospitalized and Ambulatory Patients: A Comparative Study

Background/Objectives: COVID-19 may result in persistent symptoms, some of which can be disabling, referred to as post-acute sequelae of SARS-CoV-2 (PASC, or long COVID). The growing recognition of PASC as a public health challenge underscores the need for comprehensive studies of its course, risk factors, and clinical outcomes. This multicentric study aimed to compare the prevalence, symptom spectrum, and functional impact of PASC in two patient groups: those hospitalized with COVID-19 and those managed exclusively in ambulatory care. Methods: Molecular, clinical, and demographic data were obtained from 319 patients diagnosed with COVID-19 in seven European countries. Patients were classified as PASC in accordance with the WHO definition. Results: PASC is more frequent and severe among hospitalized patients, while ambulatory patients present with milder but prolonged symptoms. Categorical age analysis suggests that older age was associated with a higher incidence of PASC, highlighting the need for multidisciplinary management and targeted support. Conclusions: Our findings highlight distinct differences in the presentation and impact of PASC across patient groups, with important implications for individualized care, multidisciplinary management, and effective healthcare planning in the post-pandemic era.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2026-05-11
DOI
https://doi.org/10.3390/jcm15103681
Primary Topic
Long-Term Effects of COVID-19
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Post-Acute Sequelae of COVID-19 (PASC) in Hospitalized and Ambulatory Patients: A Comparative Study

Marta Kepinská, Mirosław Banasik, Åsa Nilsson, G. Spasovski et al.
Journal of Clinical Medicine
Long-Term Effects of COVID-19
article

Post-Acute Sequelae of COVID-19 (PASC) in Hospitalized and Ambulatory Patients: A Comparative Study

Marta Kepinská, Mirosław Banasik, Åsa Nilsson, G. Spasovski, Patryk Wawrzonkowski, Harald Mischak, Björn Peters, Felix Keller, Morgane Michel, Fatima Zunara, Emmanuel Dudoignon, Emelie Sarenmalm, Magdalena Król-Kulikowska, Justyna Siwy, R Wendt, Mercedes Salgueira, Christian Scholz, UriCoV Working Group
article en

Abstract

Background/Objectives: COVID-19 may result in persistent symptoms, some of which can be disabling, referred to as post-acute sequelae of SARS-CoV-2 (PASC, or long COVID). The growing recognition of PASC as a public health challenge underscores the need for comprehensive studies of its course, risk factors, and clinical outcomes. This multicentric study aimed to compare the prevalence, symptom spectrum, and functional impact of PASC in two patient groups: those hospitalized with COVID-19 and those managed exclusively in ambulatory care. Methods: Molecular, clinical, and demographic data were obtained from 319 patients diagnosed with COVID-19 in seven European countries. Patients were classified as PASC in accordance with the WHO definition. Results: PASC is more frequent and severe among hospitalized patients, while ambulatory patients present with milder but prolonged symptoms. Categorical age analysis suggests that older age was associated with a higher incidence of PASC, highlighting the need for multidisciplinary management and targeted support. Conclusions: Our findings highlight distinct differences in the presentation and impact of PASC across patient groups, with important implications for individualized care, multidisciplinary management, and effective healthcare planning in the post-pandemic era.

Journal of Clinical MedicineVol. 15(10)
Innsbruck Medical University (AT), Inserm (FR), Universität Innsbruck (AT), Université Paris Cité (FR), Klinikum St. Georg (DE), Wroclaw Medical University (PL), Hospital Universitario Virgen Macarena (ES), Assistance Publique – Hôpitaux de Paris (FR), Evaluation et recherche en services et politiques en santé pour les populations vulnérables (FR), Hôpital Lariboisière (FR), Mosaiques Diagnostics and Therapeutics (Germany) (DE), Hôpital Robert-Debré (FR), KfH Kuratorium für Dialyse und Nierentransplantation (DE), Skaraborg Hospital (SE), University Hospital Cologne (DE), Ss. Cyril and Methodius University in Skopje (MK), Universidad de Sevilla (ES), University of Gothenburg (SE)
Västra Götalandsregionen, Universidad de Sevilla, Uniwersytet Jagielloński Collegium Medicum, Agence Nationale de la Recherche, Institut National de la Santé et de la Recherche Médicale, Austrian Science Fund, Universität Wien, Bundesministerium für Gesundheit, Göteborgs Universitet, Medizinische Universität Wien, Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu, Assistance publique-Hôpitaux de Paris, Śląski Uniwersytet Medyczny w Katowicach, Uniwersytet Śląski w Katowicach, Sorbonne Université, Narodowe Centrum Badań i Rozwoju, Sahlgrenska Akademin
Good health and well-being
Openalex Percentile: Top 6%
Long-Term Effects of COVID-19
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.